GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hybio Pharmaceutical Co Ltd (SZSE:300199) » Definitions » 5-Year Dividend Growth Rate

Hybio Pharmaceutical Co (SZSE:300199) 5-Year Dividend Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hybio Pharmaceutical Co 5-Year Dividend Growth Rate?

Hybio Pharmaceutical Co's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hybio Pharmaceutical Co was 58.70% per year. The lowest was -20.60% per year. And the median was -7.40% per year.

Hybio Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Hybio Pharmaceutical Co's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Hybio Pharmaceutical Co's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Hybio Pharmaceutical Co's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hybio Pharmaceutical Co's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hybio Pharmaceutical Co's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Hybio Pharmaceutical Co's 5-Year Dividend Growth Rate falls into.



Hybio Pharmaceutical Co 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Hybio Pharmaceutical Co  (SZSE:300199) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Hybio Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ -0.018
=N/A

During the past 13 years, the highest Dividend Payout Ratio of Hybio Pharmaceutical Co was 0.29. The lowest was 0.08. And the median was 0.15.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of Hybio Pharmaceutical Co was 2.46%. The lowest was 0.11%. And the median was 0.54%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hybio Pharmaceutical Co 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Hybio Pharmaceutical Co's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hybio Pharmaceutical Co (SZSE:300199) Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, Office Building, Hanyu Biomedical Park, Middle District, High-tech Industrial Park, Nanshan District, Guangdong Province, Shenzhen, CHN, 518057
Hybio Pharmaceutical Co Ltd is engaged in manufacturing and sale of peptide products. The company's peptide finished dosage products include digestive system agents, immune modulators, hormone and endocrine modulators, antiviral agents, and hemostatic products. It also provides peptide CRO and CMO services, as well as API products.

Hybio Pharmaceutical Co (SZSE:300199) Headlines

No Headlines